DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Finn RS, Qin S, Ikeda M. et al; IMbrave150 Investigators.
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
N Engl J Med 2020;
382 (20) 1894-1905
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.